Display options
Cite
Kim MJ, Koo YD, Kim M, et al. Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes. Diabetes Metab J. 2016;40(5):406-413doi: 10.4093/dmj.2016.40.5.406.
Kim, M. J., Koo, Y. D., Kim, M., Lim, S., Park, Y. J., Chung, S. S., Jang, H. C., & Park, K. S. (2016). Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes. Diabetes & metabolism journal, 40(5), 406-413. https://doi.org/10.4093/dmj.2016.40.5.406
Kim, Min Joo, et al. "Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes." Diabetes & metabolism journal vol. 40,5 (2016): 406-413. doi: https://doi.org/10.4093/dmj.2016.40.5.406
Kim MJ, Koo YD, Kim M, Lim S, Park YJ, Chung SS, Jang HC, Park KS. Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes. Diabetes Metab J. 2016 Oct;40(5):406-413. doi: 10.4093/dmj.2016.40.5.406. Epub 2016 Aug 12. PMID: 27535645; PMCID: PMC5069397.
Copy Download .nbib Format: NLM
Share it on

Diabetes Metab J. 2016 Oct;40(5):406-413. doi: 10.4093/dmj.2016.40.5.406. Epub 2016 Aug 12.

Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes.

Diabetes & metabolism journal

Min Joo Kim, Young Do Koo, Min Kim, Soo Lim, Young Joo Park, Sung Soo Chung, Hak C Jang, Kyong Soo Park

Affiliations

  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  2. Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea.
  3. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.
  4. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  5. Biomedical Research Institute and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  6. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. [email protected].

PMID: 27535645 PMCID: PMC5069397 DOI: 10.4093/dmj.2016.40.5.406

Abstract

BACKGROUND: Panax ginseng has glucose-lowering effects, some of which are associated with the improvement in insulin resistance in skeletal muscle. Because mitochondria play a pivotal role in the insulin resistance of skeletal muscle, we investigated the effects of the ginsenoside Rg3, one of the active components of P. ginseng, on mitochondrial function and biogenesis in C2C12 myotubes.

METHODS: C2C12 myotubes were treated with Rg3 for 24 hours. Insulin signaling pathway proteins were examined by Western blot. Cellular adenosine triphosphate (ATP) levels and the oxygen consumption rate were measured. The protein or mRNA levels of mitochondrial complexes were evaluated by Western blot and quantitative reverse transcription polymerase chain reaction analysis.

RESULTS: Rg3 treatment to C2C12 cells activated the insulin signaling pathway proteins, insulin receptor substrate-1 and Akt. Rg3 increased ATP production and the oxygen consumption rate, suggesting improved mitochondrial function. Rg3 increased the expression of peroxisome proliferator-activated receptor γ coactivator 1α, nuclear respiratory factor 1, and mitochondrial transcription factor, which are transcription factors related to mitochondrial biogenesis. Subsequent increased expression of mitochondrial complex IV and V was also observed.

CONCLUSION: Our results suggest that Rg3 improves mitochondrial function and the expression of key genes involved in mitochondrial biogenesis, leading to an improvement in insulin resistance in skeletal muscle. Rg3 may have the potential to be developed as an anti-hyperglycemic agent.

Keywords: Ginsenoside Rg3; Mitochondria; Panax

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

  1. Diabetes Metab J. 2013 Feb;37(1):1-21 - PubMed
  2. Biochem Biophys Res Commun. 2009 Nov 6;389(1):70-3 - PubMed
  3. Physiology (Bethesda). 2006 Feb;21:48-60 - PubMed
  4. Biol Pharm Bull. 2008 Apr;31(4):748-51 - PubMed
  5. Diabetes Care. 2000 Sep;23(9):1221-6 - PubMed
  6. Phytother Res. 2009 Apr;23 (4):486-91 - PubMed
  7. J Clin Invest. 1985 Jul;76(1):149-55 - PubMed
  8. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12017-22 - PubMed
  9. Diabetes. 2005 Jan;54(1):8-14 - PubMed
  10. FASEB J. 2005 Jul;19(9):1146-8 - PubMed
  11. Biochem Biophys Res Commun. 2013 Nov 8;441(1):169-74 - PubMed
  12. Arch Intern Med. 2000 Apr 10;160(7):1009-13 - PubMed
  13. Nature. 2001 Dec 13;414(6865):799-806 - PubMed
  14. Diabetes. 2002 Jun;51(6):1851-8 - PubMed
  15. Metabolism. 2009 Jan;58(1):8-15 - PubMed
  16. Gen Comp Endocrinol. 2002 Aug;128(1):44-56 - PubMed
  17. J Appl Physiol (1985). 2008 Feb;104(2):429-38 - PubMed
  18. J Biol Chem. 2010 Jan 1;285(1):142-52 - PubMed
  19. Biochem Pharmacol. 1999 Dec 1;58(11):1685-93 - PubMed
  20. J Ethnopharmacol. 2011 Sep 1;137(1):245-50 - PubMed
  21. Biochem Biophys Res Commun. 2007 Apr 13;355(3):734-9 - PubMed
  22. Cell Metab. 2005 Jan;1(1):15-25 - PubMed
  23. Annu Rev Physiol. 2009;71:177-203 - PubMed
  24. Med Sci Sports Exerc. 2004 Jan;36(1):28-34 - PubMed
  25. Arch Pharm Res. 2007 May;30(5):587-95 - PubMed
  26. J Diabetes Investig. 2012 Jun 6;3(3):309-17 - PubMed

Publication Types